A polymer-coated curcumin co-crystal composite nanoparticle and its preparation and application in pharmaceuticals
A technology of composite nanoparticles and curcumin coating, applied in the field of medicine, can solve the problems of low encapsulation efficiency of coated nanoparticles, wide solid particle size distribution, organic solvent residue, etc., and achieve mild and controllable treatment conditions, solvent-free Residue, solubility improvement effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] Dispersion of curcumin-2-aminopyridine co-crystal compound into liquefied CO in the dark 2 middle. will CO 2 (containing curcumin-2-aminopyridine eutectic compound) is pumped into the autoclave, and after the temperature of the autoclave reaches the preset value of 35°C and the pressure is 10MPa and stabilizes for 5min, the concentration is pumped in at a flow rate of 0.5ml / min It is 5mg / ml PVP-k30 aqueous solution, wherein the mass ratio of PVP-k30 and curcumin-2-aminopyridine cocrystal compound is 5:1. After the solution is pumped, continue to pass through the CO 2 After 0.5h, stop feeding CO 2 , release the pressure, and collect the particles in the reactor to obtain the curcumin eutectic composition nanoparticles. Its average particle diameter is 610nm, and the encapsulation efficiency is 75%.
[0052] Morphology Analysis of Curcumin Co-crystal Composition Nanoparticles
[0053] Take a small amount of composite nanoparticles prepared in this case, add an appro...
Embodiment 2
[0055] Dispersion of curcumin-4-aminophenol co-crystal compound into liquefied CO in the dark 2 middle. will CO 2 (containing curcumin-4-aminophenol eutectic compound) is pumped into the autoclave, and after the temperature of the autoclave reaches the preset value of 35°C and the pressure is 10MPa and stabilizes for 5min, the concentration is pumped in at a flow rate of 1.0ml / min It is 15mg / ml PVP-k30 aqueous solution, wherein the mass ratio of PVP-k30 and curcumin-4-aminophenol eutectic compound is 20:1. After the solution is pumped, continue to pass through the CO 2 After 0.5h, stop feeding CO 2 , release the pressure, and collect the particles in the reactor to obtain the curcumin eutectic composition nanoparticles. Its average particle diameter is 890nm, and the encapsulation efficiency is 73%.
Embodiment 3
[0057] Dispersion of curcumin-2,5-dihydroxybenzoic acid co-crystal compound into liquefied CO in the dark 2 middle. will CO 2 (containing curcumin-2,5-dihydroxybenzoic acid eutectic compound) is pumped into the autoclave, and after the temperature of the autoclave reaches 35°C and the pressure is the preset value of 20MPa and stabilizes for 5min, the A F68 aqueous solution with a concentration of 20 mg / ml was pumped in at a flow rate, wherein the mass ratio of F68 and curcumin-2,5-dihydroxybenzoic acid eutectic compound was 10:1. After the solution is pumped, continue to pass through the CO 2 After 0.5h, stop feeding CO 2 , release the pressure, and collect the particles in the reactor to obtain the curcumin eutectic composition nanoparticles. Its average particle diameter is 730nm, and the encapsulation efficiency is 69%.
PUM
| Property | Measurement | Unit |
|---|---|---|
| particle diameter | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
| particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 

